John P. Klein

Active 1981–2024

91
Papers
26,228
Citations
79
h-index
88
i10-index

Citations

Citations per year for John P. Klein1981: 2 citations1982: 3 citations1983: 5 citations1984: 2 citations1985: 7 citations1986: 11 citations1987: 4 citations1988: 5 citations1989: 6 citations1990: 6 citations1991: 2 citations1992: 4 citations1993: 8 citations1994: 14 citations1995: 12 citations1996: 13 citations1997: 17 citations1998: 46 citations1999: 55 citations2000: 100 citations2001: 107 citations2002: 141 citations2003: 162 citations2004: 138 citations2005: 155 citations2006: 174 citations2007: 210 citations2008: 226 citations2009: 248 citations2010: 356 citations2011: 280 citations2012: 279 citations2013: 284 citations2014: 268 citations2015: 266 citations2016: 202 citations2017: 183 citations2018: 180 citations2019: 487 citations2020: 420 citations2021: 385 citations2022: 205 citations2023: 117 citations2024: 235 citations2025: 72 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,751 citing papers, 29.7% of this breakdownUnited Kingdom: 667 citing papers, 7.2% of this breakdownGermany: 573 citing papers, 6.2% of this breakdownFrance: 504 citing papers, 5.4% of this breakdownItaly: 468 citing papers, 5% of this breakdownCanada: 417 citing papers, 4.5% of this breakdownNetherlands: 319 citing papers, 3.4% of this breakdownSpain: 310 citing papers, 3.3% of this breakdownChina: 275 citing papers, 3% of this breakdownJapan: 246 citing papers, 2.7% of this breakdownSwitzerland: 231 citing papers, 2.5% of this breakdownAustralia: 202 citing papers, 2.2% of this breakdown
0%29.7%Other 24.9%

Fields

  • Medicine61.9%
  • Mathematics9.1%
  • Immunology and Microbiology7.8%
  • Biochemistry, Genetics and Molecular Biology4.9%
  • Computer Science4%
  • Engineering2.4%
  • Other9.9%

Topics

  • Hematopoietic Stem Cell Transplantation11.6%
  • Immune Cell Function and Interaction4.2%
  • Acute Myeloid Leukemia Research3.8%
  • T-cell and B-cell Immunology3.6%
  • Acute Lymphoblastic Leukemia research3.5%
  • Statistical Methods and Inference3%
  • Other70.3%

Coauthors

All papers

Open in search
  1. Survival Analysis

    Authors: , - Statistics for biology and health 1997 cited by 1,781

  2. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

    Authors: , , , , , , , , , , , , , , , , , - Blood 2007 cited by 1,240

  3. Analyzing survival curves at a fixed point in time

    Authors: , , , - Statistics in Medicine 2007 cited by 314

  4. IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE

    Authors: , , , , , , , , , , , , , - British Journal of Haematology 1997 cited by 691

  5. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

    Authors: , , , , , , , , , , , , , - Blood 2010 cited by 583

  6. Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2014 cited by 128

  7. Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 1999 cited by 701

  8. A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model

    Authors: , , , - Computer Methods and Programs in Biomedicine, Comput. Methods Programs Biomed. 2007 cited by 281

  9. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure

    Authors: , , , , , , , - Blood 2010 cited by 273

  10. Regression Analysis of Restricted Mean Survival Time Based on Pseudo-Observations

    Authors: , , - Lifetime Data Analysis 2004 cited by 212

  11. Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 155

  12. Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 cited by 442

  13. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

    Authors: , , , , , , , , , , - The Lancet 2007 cited by 794

  14. Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation

    Authors: , , , , , , , , , , , , , , , , - Blood 2013 cited by 157

  15. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

    Authors: , , , , , , , , , , - Blood 2008 cited by 434

  16. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

    Authors: , , , , , , , , , , , , , , , - Blood 2007 cited by 291

  17. Additive Manufacturing of Optically Transparent Glass

    Authors: , , , , , , , , , , - 3D Printing and Additive Manufacturing 2015 cited by 280

  18. Testing for centre effects in multi‐centre survival studies: a Monte Carlo comparison of fixed and random effects tests

    Authors: , , - Statistics in Medicine 1999 cited by 226

  19. HLA-C Antigen Mismatch Is Associated with Worse Outcome in Unrelated Donor Peripheral Blood Stem Cell Transplantation

    Authors: , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2010 cited by 209

  20. Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2009 cited by 154

  21. Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia

    Authors: , , , , , , , , , , , , - The Journal of Immunology 2014 cited by 148

  22. Survival Analysis Techniques for Censored and Truncated Data

    Authors: , , - Technometrics 1998 cited by 3,589

  23. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 1997 cited by 475

  24. Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT

    Authors: , , , , , , , , , , , - Blood 2007 cited by 285